Danuta Kielar

1.2k total citations
25 papers, 975 citations indexed

About

Danuta Kielar is a scholar working on Rheumatology, Surgery and Immunology. According to data from OpenAlex, Danuta Kielar has authored 25 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 11 papers in Surgery and 9 papers in Immunology. Recurrent topics in Danuta Kielar's work include Rheumatoid Arthritis Research and Therapies (10 papers), Spondyloarthritis Studies and Treatments (8 papers) and Psoriasis: Treatment and Pathogenesis (6 papers). Danuta Kielar is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Spondyloarthritis Studies and Treatments (8 papers) and Psoriasis: Treatment and Pathogenesis (6 papers). Danuta Kielar collaborates with scholars based in Germany, United States and Netherlands. Danuta Kielar's co-authors include Bengt Hoepken, C. Stach, T. Arledge, Philip J. Mease, Roy Fleischmann, Franz Woltering, Atul Deodhar, J. Wollenhaupt, Désirée van der Heijde and Majed Khraishi and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Clinical Chemistry.

In The Last Decade

Danuta Kielar

23 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danuta Kielar Germany	12	406	404	246	220	213	25	975
Chaohuan Guo China	16	580 1.4×	317 0.8×	97 0.4×	110 0.5×	568 2.7×	20	1.1k
Won Tae Chung South Korea	20	172 0.4×	475 1.2×	58 0.2×	82 0.4×	246 1.2×	59	914
Andrea Di Domenicantonio Italy	10	227 0.6×	115 0.3×	67 0.3×	23 0.1×	185 0.9×	18	983
Stacy L. Musone United States	10	347 0.9×	134 0.3×	175 0.7×	21 0.1×	291 1.4×	10	1.0k
Juan Shan China	16	387 1.0×	121 0.3×	126 0.5×	45 0.2×	248 1.2×	42	857
Shufang Gu United States	12	281 0.7×	25 0.1×	76 0.3×	114 0.5×	247 1.2×	13	807
Rosa Elena Navarro-Hernández Mexico	17	266 0.7×	241 0.6×	19 0.1×	45 0.2×	134 0.6×	49	683
Erik H. Offerman Netherlands	12	251 0.6×	29 0.1×	333 1.4×	47 0.2×	271 1.3×	16	830
Ichiro Horie Japan	18	216 0.5×	81 0.2×	190 0.8×	12 0.1×	219 1.0×	63	876
Ronan Calvez United Kingdom	11	403 1.0×	43 0.1×	63 0.3×	123 0.6×	450 2.1×	16	962

Countries citing papers authored by Danuta Kielar

Since Specialization

Citations

This map shows the geographic impact of Danuta Kielar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danuta Kielar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danuta Kielar more than expected).

Fields of papers citing papers by Danuta Kielar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danuta Kielar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danuta Kielar. The network helps show where Danuta Kielar may publish in the future.

Co-authorship network of co-authors of Danuta Kielar

This figure shows the co-authorship network connecting the top 25 collaborators of Danuta Kielar. A scholar is included among the top collaborators of Danuta Kielar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danuta Kielar. Danuta Kielar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kielar, Danuta, et al.. (2023). Real-World Investigation of Eosinophilic-Associated Disease Overlap (REVEAL): Analysis of a US Claims Database. Allergy Asthma and Immunology Research. 15(5). 580–580. 3 indexed citations

Kielar, Danuta, Andrew Jones, Xia Wang, et al.. (2023). Association Between Elevated Blood Eosinophils and Chronic Kidney Disease Progression: Analyses of a Large United States Electronic Health Records Database. International Journal of Nephrology and Renovascular Disease. Volume 16. 269–280. 4 indexed citations

Blackburn, Steven, et al.. (2016). Association of Patient-Reported Anxiety and Depression with Clinical Measurements, Disability, and Treatment Satisfaction Among Patients with Rheumatoid Arthritis. Value in Health. 19(7). A544–A544. 1 indexed citations

Mease, Philip, R Fleischmann, J. Wollenhaupt, et al.. (2013). EFFECT OF CERTOLIZUMAB PEGOL ON SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS WITH OR WITHOUT PRIOR ANTI-TNF EXPOSURE : 24-WEEK RESULTS OF A PHASE III DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY. Lara D. Veeken. 52(10). 162–163. 4 indexed citations

Heijde, D. van der, Roy Fleischmann, J. Wollenhaupt, et al.. (2013). Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol. Annals of the Rheumatic Diseases. 73(1). 233–237. 60 indexed citations

Mease, Philip J., Roy Fleischmann, Atul Deodhar, et al.. (2013). Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Annals of the Rheumatic Diseases. 73(1). 48–55. 360 indexed citations

Landewé, Robert, Martín Rudwaleit, Désirée van der Heijde, et al.. (2013). OP0106 Effect of Certolizumab Pegol on Signs and Symptoms of Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 24-Week Results of Rapid-Axspa Study. Annals of the Rheumatic Diseases. 72. A86–A87. 4 indexed citations

Heijde, Désirée van der, Walter P. Maksymowych, Robert Landewé, et al.. (2013). FRI0419 Effect of certolizumab pegol on inflammation of spine and sacroiliac joints in patients with axial spondyloarthritis: 12-week magnetic resonance imaging results of rapid-axspa study. Annals of the Rheumatic Diseases. 72. A515–A516. 5 indexed citations

Landewé, Robert, Martín Rudwaleit, Désirée van der Heijde, et al.. (2012). Effect of Certolizumab Pegol On Signs and Symptoms of Ankylosing Spondyltitis and Non-Radiographic Axial Spondyloarthritis : 24 Week Results of a Double Blind Randomized Placebo-Controlled Phase 3 Axial Spondyloarthritis Study. Data Archiving and Networked Services (DANS). 64(10). 10 indexed citations

10.

Müller‐Ladner, Ulf, et al.. (2012). Comparison of patient satisfaction with two different etanercept delivery systems. Zeitschrift für Rheumatologie. 71(10). 890–899. 14 indexed citations

11.

Mease, Philip J., Roy Fleischmann, Ajita Deodhar, et al.. (2012). LB0001 Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24 week results of a phase 3 double blind randomized placebo-controlled study (rapid-PSA). Annals of the Rheumatic Diseases. 71. 150–151. 5 indexed citations

12.

Paul, C., J.F. Stalder, Diamant Thaçi, et al.. (2011). Patient satisfaction with injection devices: a randomized controlled study comparing two different etanercept delivery systems in moderate to severe psoriasis. Journal of the European Academy of Dermatology and Venereology. 26(4). 448–455. 22 indexed citations

13.

Moots, Robert J., Andrew J.K. Östör, Anne Gitte Loft, et al.. (2011). Reduction of direct and indirect costs in patients with AS receiving etanercept: results from an open-label 36-week extension of the ASCEND study in four European countries. Lara D. Veeken. 51(2). 393–396. 6 indexed citations

14.

Kielar, Danuta, Wolfgang E. Kaminski, Gerhard Liebisch, et al.. (2003). Adenosine Triphosphate Binding Cassette (ABC) Transporters Are Expressed and Regulated During Terminal Keratinocyte Differentiation: A Potential Role for ABCA7 in Epidermal Lipid Reorganization. Journal of Investigative Dermatology. 121(3). 465–474. 61 indexed citations

15.

Langmann, Thomas, Mustafa Özçürümez, Susanne Heimerl, et al.. (2002). Identification of Sterol-independent Regulatory Elements in the Human ATP-binding Cassette Transporter A1 Promoter. Journal of Biological Chemistry. 277(17). 14443–14450. 57 indexed citations

16.

Bodzioch, Marek, Matthias Krüll, Danuta Kielar, et al.. (2001). Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1537(1). 42–48. 24 indexed citations

17.

Brousseau, Margaret E., Marek Bodzioch, Ernst J. Schaefer, et al.. (2001). Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis. 154(3). 607–611. 76 indexed citations

18.

Kielar, Danuta, Wolfgang Dietmaier, Thomas Langmann, et al.. (2001). Rapid Quantification of Human ABCA1 mRNA in Various Cell Types and Tissues by Real-Time Reverse Transcription-PCR. Clinical Chemistry. 47(12). 2089–2097. 89 indexed citations

19.

Kielar, Danuta, Jeremy S. C. Clark, Andrzej Ciechanowicz, et al.. (1998). Leptin receptor isoforms expressed in human adipose tissue. Metabolism. 47(7). 844–847. 98 indexed citations

20.

Shimizu, Yasutake, Danuta Kielar, Hiroshi Masuno, Yasuhiko Minokoshi, & Takashi Shimazu. (1994). Dexamethasone Induces the GLUT4 Glucose Transporter, and Responses of Glucose Transport to Norepinephrine and Insulin in Primary Cultures of Brown Adipocytes1. The Journal of Biochemistry. 115(6). 1069–1074. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact